• Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 Dual-targeting CAR-T GC012F in RRMM and B-NHL and CD19/CD7 Dual-directed Allogeneic CAR-T GC502 in B-ALL at EHA2022 Congress

    15 days ago - By San Diego Biotechnology

    SAN DIEGO, Calif., SUZHOU and SHANGHAI, China , May 12, 2022 /PRNewswire/ - Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell...
    Read more ...

     

  • Ionis to present at RBC Capital Markets Global Healthcare Conference

    16 days ago - By San Diego Biotechnology

    CARLSBAD, Calif., May 12, 2022 /PRNewswire/ - Ionis Pharmaceuticals, Inc. today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 18, 2022. A live webcast and...
    Read more ...